RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York